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Finite dose experiments represent clinical use wherein depletion of dose, evaporation 
of excipients, and gradual change in vehicle composition may occur. In the present study, we 35 
attempted a mathematical approach for predicting skin permeation and concentration of a 
cosmetic active, rhododendrol (RD), from complex vehicle-based formulations applied in 
finite dose. In vitro skin permeation and concentration studies of RD were conducted from 
formulations containing water and polyols with concentrations ranging from 10 – 100% under 
infinite and finite dose conditions using vertical Franz diffusion cells. Observed data for skin 40 
permeation and the viable epidermis and dermis (VED) concentration of RD were estimated 
by the differential equations under Fick’s second law of diffusion together with water 
evaporation kinetics and changes in the partition coefficient from vehicles to the stratum 
corneum. As a result, a goodness-of-fit was observed allowing accurate estimation of skin 
permeation and VED concentration of RD. This mathematical approach could become a useful 45 
tool to estimate the skin permeation and concentration of actives from topical formulation 
applied in finite dose conditions likened in actual use.  
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A number of cosmetic formulations are made of quasi-drugs (active compounds) 
effectively dissolved in complex vehicle systems. These formulations may contain components 60 
that enhance or decrease the penetration of active compound or other components. In addition, 
vehicle composition may change after topical application due to low amount of formulation 
applied. Therefore, the permeation of chemicals from a small amount of topically applied 
formulation in its in-use conditions is difficult to simulate experimentally. The finite dose 
experiment is supposed to best represent its clinical use (i.e, in-use conditions) wherein 65 
depletion of dose and evaporation of the excipients may occur. Investigating the percutaneous 
absorption of chemicals, under its in-use conditions, has been presented with huge challenges 
associated with incomplete recovery of the applied formulation, low extraction ratio of 
compounds from the skin, and inter-run variabilities for key parameters (e.g., skin permeability, 
partition coefficient from vehicle to skin) in such experiments (Selzer et al., 2013). To date, no 70 
definitive method has been established to address these challenges.  
On the other hand, the penetration of chemicals from aqueous vehicles in infinite dose 
models under steady-state conditions (i.e., non-depleting dose) can generally be predicted 
based on their physicochemical properties (Magnusson et al., 2004; Uchida et al., 2015). 
However, steady-state conditions are typically unattainable in finite dose experiments where 75 
dose depletion takes place. The assumption of steady-state conditions does not apply to finite 
dose experiments since a high evaporation rate of applied solvents occurs after application. 
Generally, rapid evaporation of solvents occurs, which significantly alters the effective 
diffusion area of the applied formulation and the composition of the resulting residual 
formulation after formulations are applied on the skin (Arce, et al., 2019; Otto, et al., 2008; 80 
Poulsen, 1973). In contrast, the majority of studies done to asses this phenomenon were 
performed with infinite dose conditions, whereas only a limited number of studies have been 
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conducted for finite dose conditions. Hence, caution must be considered in extrapolating data 
derived from infinite dose experiments or experiments in which exposure occurs via simple 
aqueous vehicles, because these do not necessarily reflect the complexities of most 85 
formulations used in practice. In addition, few studies have been conducted to predict skin 
permeation in finite dose settings with the use of actual cosmetic formulations. Appropriate 
alternatives in modeling this phenomenon must then be adopted to enhance this point and better 
predict skin permeation for in-use conditions. Predicting skin permeation of cosmetic active 
compounds in finite dose settings will not only provide insights on local toxicity but also allow 90 
prediction of its systemic absorption.  
In our previous work, we demonstrated the impact of in-use conditions such as layered 
application, evaporation in formulations, and sequential and concurrent application of polyols 
with cosmetic formulation in the skin permeation of cosmetic active compounds. Layered 
application of cosmetics and concurrent application of polyols dramatically reduced the skin 95 
permeation of active compounds (Arce et al., 2019). Findings from various reports had 
diverging claims on the roles of solubility in the skin permeation of chemicals under finite dose 
conditions (Karadzovska et al., 2013; Wiechers et al., 2012; Lane et al., 2012). Several studies 
have focused on estimating the amount of chemical permeating through the skin based on the 
physicochemical properties of permeants and formulations, yet they neglected the essential role 100 
of evaporation in the actual permeation of chemicals (Potts and Guy, 1992; Dias et al., 2007; 
Uchida et al., 2015). Furthermore, little is known about what governs the skin permeation and 
concentration of chemicals applied as a finite dose.  
The efficacy and safety of cosmetics and locally acting drugs applied on skin are 
determined by their distribution into its intended site of action, most likely the viable epidermis 105 
and dermis (VED), and not the stratum corneum (SC). Skin whitening agents from cosmetics 
or steroids and antimicrobials from topical medications must be studied for their distribution 
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and concentration in the VED (Sugibayashi et al., 2010). The epidermal layers being the 
primary site of action for these products offer direct insights for safety assessments or product 
optimization. The importance of the concentration in the VED is greater for cosmetics and 110 
topical medications that are capable of causing skin irritation and inflammation (Oshizaka et 
al., 2014). In recent times, the toxicity of cosmetic active compounds may be represented well 
by reports on rhododendrol (RD)– related leukoderma. In this case, evaluation methods for 
dermatological products based upon appropriate skin models and in-use conditions are 
important to confirm dose-dependent toxicity of compounds at the site of action. Determining 115 
the distribution of chemicals in the VED is of great significance for cosmetic formulations, 
where they are expected to maintain their effective concentrations. Quantification of permeant 
concentration in the skin allows a high precision in predicting their efficacies or toxicities.  
Establishing mathematical models aimed at predicting skin or VED concentration of 
chemicals entails understanding of the factors that influence skin permeation. Therefore, this 120 
investigation probed the possible role of evaporation and the composition of residual 
formulations on the skin permeation and concentration in finite dose conditions. The actual 
impact of vehicle on the skin permeation and concentration of the penetrant can be realistically 
clarified by simulating the residual formulation based on evaporation kinetics from applied 
formulations. We employed various polyols commonly used as solvents in cosmetics and 125 
simulated residual formulations composed of high polyol proportions to reveal its role in the 
skin permeation of active compounds. Here, we propose a method that allows investigation of 
the permeant disposition from residual formulations encompassing evaporation, which is a 
natural process during use. This is an extension of our inquiry on the fate of cosmetic active 
compounds from complex formulations in actual product in-use conditions (e.g., layered 130 
application, finite dose conditions). Experiments in steady-state conditions for simulated 
residual formulations were conducted to allow surrogate estimation of skin permeation 
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parameters in finite dose exposures. In the present study, we attempted to establish a 
mathematical method in predicting skin permeation and the concentration of cosmetic active 
compounds applied in finite dose from a complex vehicle-based formulation. 135 
 
2.  MATERIALS AND METHODS 
2.1. Materials 
RD (CAS no. 501-96-2, ³ 99%) was supplied by Kanebo Cosmetics, Inc. (Tokyo, 
Japan). Methylparaben and glycerin were purchased from Fujifilm Wako Pure Chemicals 140 
Industries, Ltd. (Osaka, Japan). Sorbitol, trichloroacetic acid and 1,3-butylene glycol (BG) 
were purchased from Tokyo Chemical Industry, Co. Ltd (Tokyo, Japan) while dipropylene 
glycol (DPG) was purchased from Sigma Aldrich Chimie (Saint-Quentin-Fallavier, France).  
The complex vehicle, a recalled lotion of RD, was supplied by Kanebo Cosmetics, Inc. 
It was primarily composed of water and a mixture of polyols (DPG, glycerin, BG, and sorbitol; 145 
each concentration is shown in 2.2). 
 
2.2. Preparation of RD formulations 
Aqueous formulation of RD (1%) (Table 1) was prepared by dissolving RD in a 
sufficient amount of purified water in a volumetric flask. An RD concentration of 1% was 150 
selected instead of 2% due to its limited solubility with water.  
The polyol mixture was composed of DPG (46.15%), glycerin (23.08%), BG (20.51%), 
and sorbitol (10.26%) identical to that of the recalled formulation. A prepared lotion 
formulation (2% RD) containing identical total polyol concentration, 19.5% and water, of the 
recalled lotion, was also prepared (Table 1).  155 
To reflect formulation conditions in the residual phase, formulations depicting polyol 
concentration following evaporation were developed. Simulated residual formulations of RD 
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(2%) lotion were designed to reflect varying degrees of evaporation from the formulation hence, 
polyol concentrations of 40%, 61.8%, and 100% (Table 1) were adopted. These polyol 
concentrations were particularly selected to reflect low, middle, and high degrees of water 160 
evaporation from the residual phase. These formulations were prepared by addition of a 
sufficient amount of purified water with its corresponding polyol proportions in a volumetric 
flask.  
 
2.3. In vitro skin permeation experiment 165 
Frozen porcine ears (Central Institute for Feed and Livestock; JA Zen-Noh, Tsukuba, 
Ibaraki, Japan) were thawed with warm water and rinsed with purified water. Hairs were 
trimmed and shaved, and subcutaneous fats were excised off the skin. Skin was harvested from 
the central dorsal region of the ears. Before excision, visual inspection was performed to ensure 
the integrity of the skin. Only intact and damage-free skin was excised. For stripped skin, 170 
adhesive tape was applied on the SC side and stripped 20 times prior to excision. Isolated 
porcine skin was set on vertical type Franz diffusion cells (effective diffusion area of 1.77 cm2). 
Skin surface temperature was maintained at 32°C throughout the experiment. The receiver 
compartment was filled with 6.0 mL of purified water. Prior to the application of doses, the 
skin was applied with purified water (1.0 mL) to facilitate equilibration for 1 h. Water was then 175 
carefully removed and skin surface was blotted with a cotton swab to remove excess water. 
Using a positive displacement micropipette, RD formulations (1% RD aqueous, 2% RD in 
19.5% polyol, 2% RD in 40% polyol, 2% RD in 61.8% polyol, 2% RD in 100% polyol) were 
applied as either finite (17.7 µL/ 1.77 cm2) or infinite dose (1.0 mL/1.77 cm2). At a 
predetermined schedule, an aliquot (500 µL) was withdrawn from the receiver solution. 180 
Permeation experiments were performed for 0 – 4 h or 0 – 8 h. 
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2.4. Skin concentration experiment 
 The skin concentration of RD was determined using identical experimental conditions 
as the skin permeation experiment using both intact and stripped skin. Formulations were 185 
applied in infinite and finite doses. Skins were demounted from the diffusion cells and adhering 
formulations were removed at 4 h and 8 h after the start of skin permeation experiment. Skins 
were rinsed thrice on both sides with purified water and blotted dry with tissue paper. Tape-
stripping (20 times) was performed on the intact skin to isolate the VED. A sample (0.05 g) of 
the VED was reduced in size using a pair of scissors. Then, water was added and the skin was 190 
homogenized using a Polytron PT 1200E (Kinematica, Inc., Luzern, Switzerland) for 5 min. 
Samples were deproteinized by the addition of 16% trichloroacetic acid. The samples were 
agitated using a vortex mixer for 15 min, followed by centrifugation (15,000 rpm, 4°C) for 5 
min. The supernatant liquid was prepared for quantification. 
 195 
2.5. Water evaporation from formulation experiment 
 Evaporation of water from the recalled formulation was determined gravimetrically by 
monitoring weight loss of the applied solvent/formulation over time. The weight of an empty 
glass-bottom dish was first measured using an analytical balance (AUW220D; Shimadzu, 
Kyoto, Japan). Balance reading was deemed stable when differing readings are less than ± 200 
0.0001 g within 3 min. A finite dose (17.7 µL) of lotion was evenly applied using a micropipette 
and the initial weight of the applied formulation was recorded. The set-up was placed on a 
thermostatically (32°C) maintained heating plate (AS ONE, Osaka, Japan). Surface 
temperature was monitored (32 ± 1°C) using probe and infrared thermometers throughout the 
experiment. Water loss (weight of the setup) was recorded over time at intervals of 1 min until 205 
constant weight was attained.  
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2.6. Solubility of RD in residual formulations 
The solubility of RD was performed in a wide range of polyol concentrations (10.0%, 
19.5%, 40.0%, 61.8%, and 100%) simulating various stages of evaporation in the residual 210 
formulations based on our previous work (Arce et al., 2019). The excess amount of RD was 
stirred inside a capped vial immersed in a thermostatically controlled water bath (32°C) for 48 
h. This approximated the solubility of RD in the residual formulation on skin. Dissolved RD 
in solvents/simulated residual formulations were filtered and analyzed using high-performance 
liquid chromatography (HPLC).  215 
 
2.7. Quantification method for RD 
 RD was analyzed using HPLC as described previously (Arce et al., 2019). Briefly, 100 
µL of samples were added with an equal amount of internal standard (methylparaben) and 
centrifuged at 4°C for 5 min. Samples were injected into an HPLC system and analyzed for 220 
RD concentration at 280 nm. 
 
2.8. Theoretical 
2.8.1. Concentration-distance profile of a penetrant in SC and VED 
Skin diffusion model of a penetrant is generally expressed in its concentration-distance 225 
profile as shown in Figure 1. As such, a two-layered diffusion model can be used for penetrant 
diffusion through the full-thickness skin (SC + VED double membrane) while one-layered 
diffusion model is sufficient for SC-stripped skin (VED single membrane). 
2.8.2. Fick’s second law of diffusion and related initial and boundary conditions 
 In the case of a two-layered diffusion model under infinite dose condition, SC and VED 230 
concentration of a penetrant (Csc, and Cved) at position, x, and time, t, can be described by the 
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following Fick’s second law of diffusion described in our previous papers (Hada et al., 2005; 






        (1) 






        (2) 
 
where Dsc and Dved are the effective diffusion coefficients of a penetrant in SC and VED, 
respectively.  
 Initial and boundary conditions for penetrant concentration in infinite dose system were 240 
as follows:  
 
t=0  −𝐿	$% < 	𝑥	 < 	0 𝐶$% = 0        (3) 
 
0 < 	𝑥	 < 	 𝐿'()  𝐶'() = 0 245 
 
t>0  𝑥 = −𝐿$%    𝐶$% =	𝐾$% ∙ 𝐶'         (4) 
      
    𝑥 = 0   𝐶'() =	𝐾'() ∙ 𝐶$%   and   
 250 








𝑥 = 𝐿'()   𝐶'() = 0                    
 
where Lsc and Lved are the thicknesses of SC and VED, respectively; Ksc and Kved are the 255 
partition coefficients of the penetrant from the donor (vehicle) to SC and VED, respectively; 
Cv is penetrant concentration in the applied formulation (donor or vehicle). In the present RD 
permeation experiments through excised porcine ear skin, Lsc and Lved were set to be 20 µm 
and 1480 µm, respectively. 
Against Eq. (4) for the infinite dose system, the boundary condition only at x = 0 in the 260 
finite dose system becomes,  
 t > 0 𝑥 = −𝐿$% 𝐶$% =	𝐾$% ∙ 𝐶'              (4’) 
 








𝑥 = 𝐿'() 𝐶'() = 0 
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where Vv is the volume of the vehicle (donor solution). The equation in the second line in Eq. 
(4’) means that the decreased flux of the penetrant in the donor compartment is the same to the 
increased flux at x = 0 in the SC. When the amount of the penetrant permeated in the finite 
dose through membrane is very low, Eq. (4) can be used instead of Eq. (4’). Only a low 270 
percentage or less amount of RD permeated though skin in the case of the present RD skin 
permeation experiment, suggesting that Eq. (4) can be used for Eq. (4’) even at finite dose. 
2.8.3. Equations to determine the skin permeation rate and amount of a penetrant 
The skin permeation rate of penetrant per unit area, J, is expressed by Eq. (5) using 
Fick’s first law of diffusion. The cumulative amount of the penetrant permeated per unit area, 275 
Q, is determined by integrating Eq. (5). Q is expressed by Eq. (6). 
 





     (5) 
 




𝑑𝑡    (6) 280 
 
These equations can be applied to both the infinite and finite dose systems. 
2.8.4. Determination of Dved, Dsc, Kved and Ksc 
The Kved and Dved can be obtained from permeation experiment using SC-stripped skin 
(VED single membrane) in the infinite dose system (Hada et al., 2005). (Details are shown in 285 
2.3.6). Then, Ksc and Dsc are determined by the permeation experiment using full-thickness 
skin (SC + VED double membrane) in the infinite dose system. The obtained Kved and Dved 
values were fixed for calculating Ksc and Dsc. 
2.8.5. Determination of Cv(t) and Ksc(t) 
RD formulations consisted of water and polyol mixture (Table 1) were applied on skin 290 
in the present study. Water evaporated from the formulation whereas polyols remained on the 
skin in the present finite dose experiments. Thus, Cv and Ksc must be expressed as a function 
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of time as in Cv(t) and Ksc(t). Then, the Cv of RD in different concentrations of polyol vehicles 
(19.5%, 40%, 61.8% and 100%) was determined, and in each concentration of polyols, Cv was 
calculated using spline interpolation. Time course of the polyol concentration was determined 295 
by the water evaporation data from formulation (see 2.5 in detail). Finally, the time course of 
Cv(t) was obtained. 
In addition, Ksc of RD from vehicles composed of 19.5, 40, 61.8 and 100% polyols were 
experimentally determined by the permeation experiment through full-thickness skin using 
infinite dose conditions. Permeation experiments through stripped skin were also done as 300 
mentioned above. The Ksc of RD from each concentration of polyols in the formulation to SC 
was then calculated using spline interpolation. The time course of the polyol concentration was 
determined by the water evaporation data as above. Thus, the time course of Ksc(t) was obtained 
as like in Cv(t). 
2.8.6. Differential equations to obtain Csc and Cved at any time and any position  305 











4𝐶/3-,1 − 2𝐶/,1 + 𝐶/2-,15      (8) 
  310 
where Ci,j shows concentration of penetrant in SC or VED at an i-th skin position and a j-th 
time after starting the skin permeation experiment (both i and j are natural numbers), and Δx is 
xi+1 – xi  and Δt is tj+1 – tj.  Fick’s second law of diffusion (Eqs. (1) and (2)) is expressed using 
the following differential equations, Eqs. (7) and (8). The following, Eq. (9), was obtained from 
Eqs. (7) and (8). 315 
𝐶/,12- = 𝑟𝐷𝐶/3-,1 + (1 − 2𝑟𝐷)𝐶/,1 + 𝑟𝐷𝐶/2,1         (9) 






           (10) 
𝑄1 = 𝑄13- + 𝐽1∆𝑡                   (11) 320 
where n is the number of divisions of SC or VED. 
2.8.7. Determination of Jj and Qj 
Jj and Qj were calculated using a spreadsheet, Microsoft® Excel by setting n = 10 both 
for SC and VED. In this calculation, Δt was set to be less than 0.5 for Dsc·r or Dved·r, because 
the solution will diverse at 0.5 or more for Dsc·r or Dved·r.  Qj was calculated from Jj using Eq. 325 
(11).  First, experimentally observed Q values (Qj) at every sampling time point in the infinite 
dose system were fitted by the least-squares method calculated using a quasi-Newtonian 
method in MicrosoftÒ Excel Solver (Sato et al., 2001). Permeation parameters such as partition 
coefficients Ksc, Kved, diffusion coefficients Dsc, Dved, and permeability coefficient (Kp) were 
calculated using the analytical method described in our previous work (Hada et al., 2005). 330 
Csc, at any t, Csc(t), was calculated by the following equation:  
         (12) 
where Ksc(t) and Cv(t) are obtained as shown in 2.8.4. We inputted Csc(t) in the spreadsheet in 
the present calculation. This was a kind of sequential approach to derive the calculation method. 
2.8.8. Diagram of calculation method for Csc and Cved 335 
In this work, permeation parameters, Ksc, Kved, Dsc and Dved, from 1% RD aqueous 
solution through intact and stripped skin were initially determined in the infinite dose system. 
Figure 2 presents a detailed flow diagram to obtain Ksc(t)and Cv(t). 
 
3. RESULTS  340 
3.1. Evaporation of water from applied formulation 
Water evaporation was evaluated from a recalled lotion formulation of RD solubilized 
in a complex mixture of polyols (DPG, glycerin, BG, and sorbitol). Evaporation kinetics from 
𝐶$%(𝑡) = 𝐾$%(𝑡)・	𝐶5(𝑡) 
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the applied formulation was measured gravimetrically. The use of a glass-bottom dish allowed 
accurate measurement of water evaporation from the formulation applied as opposed to the use 345 
of isolated skin where intrinsic water loss may lead to overestimation. Observed data for water 
evaporation was in agreement with previous study (Arce et al., 2019) where ∼60% of total 
water content evaporated within the first 10 min (Fig. 3). The amount of water detected (96.3%) 
at the end of the experiment corresponded closely to the actual water content of the recalled 
formulation. Exhaustive evaporation of water from the applied formulation was observed in 350 
this study. The evaporation rate from the formulation exhibited first-order kinetics and the 
percent water loss, y, was calculated using the following equation, y = 103 x e-0.093t, where t is 
the time after the start of experiment (Fig. 3).   
 
3.2. Skin permeation of RD from aqueous formulation 355 
 Figure 4 presents the time course of the cumulative amount of RD permeated through 
intact and stripped skin. RD permeation was 13-fold higher through stripped skin from 1% RD 
aqueous solution compared with intact skin. Permeation parameters, diffusion coefficients (Dsc, 
Dved) and partition coefficients (Ksc, Kved) were obtained by curve-fitting the cumulative 
amounts of RD that permeated through intact and stripped skin to the theoretical values using 360 
a least-squares method. Table 2 shows the calculated values of the permeation parameters.  
 
3.3. Skin permeation profiles of RD from infinite dose experiments 
Figure 5A shows the cumulative amount of RD permeated through intact skin from 
lotion with different polyol concentrations (19.5% - 100%). Recalled lotion and prepared 365 
lotions, having identical proportions (19.5%) of polyols, resulted in similar skin permeation 
profiles with negligible variances. The Kved, Dsc, Dved values obtained from skin permeation 
experiments using 1% RD aqueous solution were fixed to estimate Ksc of RD formulations with 
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varying polyol concentrations (Table 3). Formulations with high polyol concentrations resulted 
in low Ksc values.  370 
 
3.4. Relationship between polyol concentration and RD permeation 
Figure 5B presents the correlation between the cumulative amount of RD that 
permeated through porcine skin and polyol concentration. When the polyol concentration 
increased from 19.5 to 40%, 61.8 and 100%, the skin permeation of RD was reduced by 1.8-, 375 
3.8-, and 28.8-fold, respectively. The skin permeation of RD exhibited a positive inverse 
correlation (r2 = 0.98) against the polyol concentration in formulation, suggesting that a high 
polyol concentration would yield lower skin permeation of RD.  
  
3.5. Solubility of RD in simulated residual formulations 380 
Solubility of RD in the simulated residual formulations revealed a positive linear 
correlation (r2 = 0.99) with the polyol concentration in the formulations (Fig. 5C). High 
solubility of RD was observed in residual formulations containing high polyol concentrations 
(90.44 to 100%) and likewise low solubility at lower polyol concentrations (19.5 – 40%) (Fig. 
5C). In residual formulation containing 61.8% polyols, wherein its water concentration was 385 
about half of its original concentration in the recalled lotion, yielded a 3-fold increase in RD 
solubility.  
Water evaporation from formulation increased polyol concentration in the residual 
phase induced changes in the Ksc (Table 3). A high polyol concentration in the formulation was 
correlated with lower Ksc values (r2 = 0.96; Ksc = 0.54e-0.052x, where x is the concentration of 390 
polyol in the formulation). 
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3.6. Prediction of skin permeation and concentration of RD from complex cosmetic 
formulations 
Figure 6 presents the time course of the cumulative amount of RD that permeated 395 
through skin and the concentration in the VED from recalled lotion. Cv was obtained from 
water evaporation in the formulations and the decrease in the amount of RD in the formulation 
by permeation through skin over time. The actual experimental data were plotted against the 
predicted values and well-fitting lines were observed in both skin permeation and concentration. 
4. DISCUSSION 400 
 In the present study, we assumed that RD solubilized in complex polyol vehicles 
penetrate the shallow segment of the SC. Hence, Kved, Dsc, Dved were fixed and used in 
estimating Ksc of RD solubilized in polyol vehicles.  This phenomenon is mainly influenced by 
two factors; high polyol concentration and water evaporation from formulation on the skin 
surface. These factors alter the drug partitioning into the SC and consequently regulate the 405 
amount of the permeants in and through the skin.  
Evaporation of volatile components from applied formulations occurs particularly in 
finite dose conditions and clinical applications. This highlights the fact that the actual 
permeation of chemicals through skin is best manifested by simulating the conditions of the 
residual formulations wherein complete evaporation occurs in the residual phase. The rate of 410 
evaporation in the residual phase of the formulation determines its effective area of diffusion. 
The increase in polyol concentration in the residual phase caused by water evaporation is thus 
a major determinant in the skin permeation of active compounds. By using a broad range of 
polyol concentrations in simulating the residual formulations, a mechanistic approach can be 
provided to investigate the impact of evaporation in the skin disposition of RD.  415 
Permeation of RD through intact and stripped porcine ear skin under infinite dose 
conditions was determined to evaluate the partition and diffusion parameters of RD. The well-
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fitting line was obtained for RD allowing estimation of the effective diffusion coefficient in 
the VED by considering evaporation kinetics (Fig. 3) and the related changes in the Cv and Ksc 
(Fig. 5C). The same observation was reported by Potts and Guy in predicting the permeability 420 
of chemicals through skin from aqueous solutions (Potts and Guy, 1992). However, this was 
not observed in the case of a finite dose since the predicted parameters yielded poor-fitting line 
and thus, imprecise estimation of RD concentration in the VED (data not shown).  
For infinite dose conditions, the formulation dynamics are maintained throughout the 
experiment with the concentration gradient favoring passive diffusion, a condition obeying 425 
Fick’s first law. However, in a finite dose setup, the permeation environment is abruptly altered 
after application of the formulation. This ‘new’ environment, residual formulation, therefore 
dictates how chemicals permeate through the skin in finite dose exposures. Otto et al. (2008) 
stressed the need to understand the impact of evaporation on the formulations and the 
consequent transformations it undergoes after application onto the skin taking into 430 
consideration that the actual permeation occurs after complete evaporation from the residual 
formulation. This is a factor largely ignored despite the fact that the residual formulation differs 
considerably from the original formulation prior to application (Poulsen, 1973). In the present 
study, the prediction of skin permeation and VED distribution was greatly improved upon 
incorporating evaporation rates of concerned formulations. A goodness-of-fit was observed for 435 
the RD permeation through porcine skin from the lotion formulation (Fig. 6).  
 Generally, evaporation from the residual formulation affects the permeation parameters. 
These parameters are determined by the interactions between the permeant and the formulation. 
It was clear in the present study that water evaporation altered the solubility of RD in the 
residual polyol vehicles. The effect of water evaporation on the skin permeation of RD from 440 
residual formulations was confirmed in infinite dose experiments, where a decrease in the skin 
permeation of RD was noted with an increase in polyol concentration in the vehicles (Fig. 5A 
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and 5B). Estimating the skin permeation parameters from a residual formulation applied as a 
finite dose has not been realistically achieved because formulations tend to evaporate 
completely leading to incomplete recovery of formulation for quantification. By simulating the 445 
composition of a residual formulation and performing permeation experiments under infinite 
dose conditions, it mimics permeation in the residual phase and allows a reliable estimation of 
parameters.  
Ideally, to increase the penetration of chemicals into the SC, the solubility of the 
permeating chemical with the SC must be enhanced by increasing its partition coefficient, Ksc 450 
or by reducing its solubility in the vehicle (Wiechers et al., 2004). In the present study, we 
found that the solubility of RD in the residual formulation, with very high polyol concentration, 
proportionally reduced Ksc through solvent evaporation. RD formulations in polyol had 
significantly lower Ksc values relative to the aqueous formulation (Fig. 5C). RD permeation 
decreased when the amount of polyol (19.5% versus polyol concentrations ³ 40%) in the 455 
residual formulation was more than the required amount to dissolve RD. Permeation and 
consequential distribution of RD in the VED appeared to be closely related to the 
thermodynamic activity of RD in the vehicle, as manifested by its partition coefficient. 
In our steady-state experiments, RD fluxes of simulated formulations with high polyol 
concentrations were shown to be reduced as the polyol concentration was increased. An inverse 460 
relationship existed between the flux and high polyol concentration (Table 3). Calculated 
permeation parameters further revealed that an increase in polyol concentration decreased flux 
and the permeability coefficient. The decrease in partition coefficient for RD in the residual 
formulation supported the observed lower permeability coefficient in relation to polyol 
concentration leading to a reduction in flux and consequently RD permeation.  465 
The unintended retention of RD on the skin surface instead of benefiting from a ‘solvent 
drag effect’ with the use of polyols, typically employed in cosmetics as solvents, can be 
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explained by its solubility in the residual formulation. In this experiment, RD was found to be 
highly soluble with specific polyols (e.g., BG, DPG) as well as increasing solubility with higher 
polyol concentration in the residual formulation. Enhancement of solubility of the permeating 470 
active compounds in the formulation (i.e., residual formulation) more than that in the SC 
resulted in reduced partitioning into the skin. The increase in its solubility will reduce its 
thermodynamic activity, thereby creating a weaker driving force for diffusion. Complete 
evaporation of volatile components from the formulation means the chemical in the residual 
phase has the same thermodynamic activity as in the simulated residual formulation composed 475 
of 100% polyol (Oliveira et al., 2012). In fact, the polyols involved in this investigation possess 
similar polarities and thus lack the ability to limit the solubility of RD. Further evidence on the 
influence of formulation polarity is the low permeability of RD through stripped skin (Fig. 4). 
Lotion formulation is presumably lipophilic and the absence of the lipophilic barrier, SC, 
generates a non-ideal diffusion interaction with the hydrophilic VED. These conditions had 480 
unfavorable effects on the formulation where the thermodynamic activity of RD was reduced 
and partitioning into the skin was hampered. Hence, RD penetrates poorly.  
Interestingly, unrealistic similarities in the skin permeation of RD were observed in 
infinite dose experiments for aqueous and prepared lotion (19.5% polyol) (Fig. 4). This 
affirmed the effect of steady-state conditions in possibly overestimating key parameters. The 485 
extent of impact of solvent evaporation and enhanced polyol concentration on RD disposition, 
however, were revealed in data obtained from residual formulations with high polyol 
concentrations (40%, 61.8%, 100%) where significantly lower values were observed. For 
formulators, seemingly acceptable permeation may be observed with formulations containing 
already desirable proportions of polyols (i.e., 19.5%) although permeation of active compounds 490 
from the residual formulation is indeed in its altered (evaporated) state.  
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Although the present study established a practical approach in estimating skin 
permeation and the concentration of RD from complex vehicles under finite dose conditions, 
other factors such as saturated formulations, other types of formulations, solvents, and cosmetic 
excipients that may affect skin permeation and concentration must be investigated further. The 495 
assumption in this study is applicable to a two-layered model where active compounds 
predominantly permeate through the SC. Hence, the contribution of the hair follicle pathway 
in the permeation of hydrophilic active compounds must be recognized in future studies.  
 
5. CONCLUSION 500 
 In conclusion, we investigated the skin permeation and concentration of an compound 
in cosmetics, RD, from a complex vehicle as how it would perform in finite dose exposure. 
Incorporating evaporation kinetics and vehicle-permeant dependent parameters (Ksc, Kved, Dsc, 
Dved) may dramatically improve the precision of mathematical models in predicting the 
permeation and distribution of active compounds in the skin. Predicting these parameters from 505 
a complex vehicle made up of actual cosmetic solvents was previously unattainable due to the 
fact that steady states were not possible in finite dose models. The use of residual formulations 
simulating the conditions (changes in polyol composition) of the applied finite dose under 
infinite experiment conditions have paved the way in the calculation of parameters and 
significantly enhanced estimation of permeant disposition. This method can be applied in the 510 
development and optimization of dermatological preparations aimed at enhancing delivery to 
the skin. Investigating realistic permeant-residual formulation interactions may further our 
understanding on the cutaneous and systemic absorption of drugs (e.g., steroids, antibiotics) 
repeatedly applied on skin, cosmetics applied in layers, and dermatological preparations (e.g., 
sunscreen and insect repellant) applied concurrently. Safety assessments of permeating 515 
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chemicals from complex vehicles in clinical and finite dose exposures may now be sufficiently 
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2% RD Lotion 
(40% Polyol) 
2% RD Lotion 
(61.8% Polyol) 
2% RD Lotion 
(100% Polyol) 
Rhododendrol 2 1 2 2 2 2 
Polyols 19.5 - 19.5 40 61.8 q.s. 100 





Table 2. Permeation parameters from RD formulations in various polyol concentration 
 Formulations 
Parameters 1% RD Aqueous  Recalled lotion  
Dsc (cm2/h) 9.0 × 10-6 4.6 × 10-6 
Dved(cm2/h) 1.8 × 10-3 1.8 × 10-3 
Ksc 0.50 0.14 




Table 3. Calculated permeation parameters of RD through intact porcine skin 600 
 Polyol concentration (%) 
Parameters  0 19.5 40 61.8 100 
J (µg/cm2/h) 8.31 ± 1.17 4.60 ± 0.74 3.37 ± 0.59 1.51± 0.12 0.21 ± 0.03 
P (cm/s) (6.55 ± 1.75) 
x 10-07 
(7.25 ± 1.16 ) 
x 10-07 
(4.09 ± 0.72) 
x 10-08 
(1.41 ± 0.13) 
x 10-08 
(1.56 ±  0.23) 
x 10-09 















Legends to Figures 
Figure 1. General concentration-distance profile of a penetrant in two-layered membrane 615 
diffusion model. Cv, Csc, Cved refers to the penetrant concentration in the vehicle, SC and VED, 
respectively; Ksc and Kved refer to partition coefficients from the donor (vehicle) to SC and 
VED, respectively; Dsc and Dved are diffusion coefficients in the SC and VED, respectively. Lsc 
and Lved refer to thicknesses of the SC and VED, respectively; and t refers to time after starting 
the permeation experiment.  620 
 
Figure 2. Flow diagram for time course of Ksc(t) and Cv(t). Cv, Csc, Cved refers to the penetrant 
concentration in the vehicle, SC and VED, respectively; Ksc and Kved refer to partition 
coefficients to SC and VED, respectively; Dsc and Dved are diffusion coefficients in the SC and 
VED, respectively. Lsc and Lved refer to thicknesses of the SC and VED, respectively; t refers 625 
to time after starting the permeation experiment.  
 
Figure 3. Percent water loss from applied formulation. Water evaporation is equal to 102.6 x 
e-0.093t (r2 = 0.98). Each point represents the mean ± S.E. (n=4). 
 630 
Figure 4. Time course of the cumulative amount of RD permeated through skin under infinite 
dose conditions. Permeation profiles from 1% aqueous RD through intact skin (●); 1% aqueous 
RD through stripped skin (○); 2% RD lotion through intact skin (◼); and 2%RD lotion through 
stripped skin (☐); line represents the predicted profiles of RD. Each point represents the mean 
± S.E. (n=4). Significant difference (*p<0.05) between 1% aqueous RD and 2% RD in 19.5% 635 
polyol through stripped skin. 
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Figure 5. Relationship of polyol concentration, RD solubility and permeation. (A) Cumulative 
RD permeation from lotion formulations through intact skin under infinite conditions; Prepared 
lotion (○); recalled lotion (☐); 2% RD in 40% polyol (◆); 2% RD in 61.8% polyol (▲); 2% 640 
RD in 100% polyol (✕). Significant difference (*p<0.05) between 2% RD in 100% polyol and 
1% aqueous RD, 2% RD in 19.5% polyol, or 2% RD in 40% polyol.  (B) Relationship between 
polyol concentration and cumulative amount of RD permeated (r2 = 0.98). 1% Aqueous RD 
(●); 2% RD in 19.5% polyol (◼); 2% RD in 40% polyol (◆); 2% RD in 61.8% polyol (▲); 
2% RD in 100% polyol (✕). (C) Relationship between polyol concentration with RD solubility 645 
(r2 = 0.99) and partition coefficient (r2 = 0.96; y = 0.54e-0.052x). 1% aqueous RD (●); 2% RD in 
10% polyol (○); 2% RD in 19.5% polyol (☐); 2% RD in 40% polyol (◆); 2% RD in 61.8% 
polyol (▲); 2% RD in 100% polyol (✕) Each point represents the mean ± S.E. (n=4).  
 
Figure 6. Time course of the cumulative amount permeated through skin (A) and concentration 650 
in VED (B) of RD recalled lotion under finite dose conditions. Unfilled circles (○) represent 
experimental data while lines represent the predicted profiles of RD. Each point represents the 





















































































































Permeation parameters were 
obtained through intact and 
stripped skin from 1% RD 
aqueous solution in infinite 
dose conditions 
Fixed values: Dsc, Kved, Dved
Obtained data from different polyol concentrations: KSC(Cpolyol concentration)
Permeation parameters were 
obtained through intact skin 
from 2% RD in various polyol 













KSC (0), Dsc, Kved, Dved
Fick’s second law of diffusion
V 5 : − 31
3'




t=0 −B CD < F < 0 H*+ = 0
0 < F < B123 H123 = 0
t>0 F = −B*+












experiment from the applied 
formulation
Relationship between 
Cpolyol concentration and KSC
④
③
H*+ = I*+ 9 H1
Cv (t)
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